You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Attenuation of haemodynamic, metabolic and energy expenditure responses to isoproterenol in patients with hypertension

Valentini, Mariaconsueloa; Julius, Stevoa; Palatini, Paolob; Brook, Robert Da; Bard, Robert La; Bisognano, John Dc; Kaciroti, Nikoa

Journal of Hypertension:
Original Papers: Obesity and Metabolic Syndrome

Objective: Overweight and heightened sympathetic activity are more common in hypertensive than normotensive subjects. β-adrenoceptor down-regulation has been described in hypertension. We tested the hypothesis that chronic sympathetic overactivity impairs β-adrenergic-mediated thermogenesis and thereby favours gain of weight in hypertension.

Participants: The study included 13 hypertensive subjects aged 35.3 ± 7.9 years and 25 normotensive subjects of control of similar age.

Methods: To measure β-adrenergically mediated haemodynamic, metabolic and thermogenic responsiveness, increasing doses of isoproterenol diluted in 2.5 ml saline were injected as intravenous boluses (0.1, 0.25, 0.5, 1.0 and 2.0 μg/m2). On a separate day, isoproterenol was infused continuously intravenously in increasing doses (10, 20 and 40 ng/kg per min), each dose for 30 min.

Results: The sitting heart rate and body mass were greater in hypertensives (P = 0.000, and P = 0.005, respectively). The heart rate responses to 1 and 2 μg/m2 isoproterenol bolus (P = 0.01 and P = 0.03, respectively) were reduced in hypertensives. The energy expenditure (P = 0.002) and oxygen consumption (P = 0.0004) increase with 40 ng/kg per min isoproterenol infusion, and glucose and phosphate responses at both 20 (P = 0.01 and P = 0.05) and 40 (P = 0.001 and P = 0.02) ng/kg per min isoproterenol infusion were attenuated in hypertensives. The baseline heart rate negatively correlated with heart rate (P = 0.015) response to isoproterenol bolus and blood pressure (P = 0.02) response to isoproterenol infusion. The urinary noradrenaline negatively correlated with heart rate response to isoproterenol bolus (P = 0.001), and with systolic blood pressure (P = 0.02) and energy expenditure responsiveness to isoproterenol infusion (P = 0.04). Furthermore, plasma noradrenaline negatively correlated with heart rate responsiveness to isoproterenol bolus (P = 0.004).

Conclusions: These results show a generalized decrease of β-adrenergic responsiveness in stage 1 hypertension and support the concept that sympathetic overactivity, via down-regulation of β-adrenoceptor-mediated thermogenic responses, may facilitate the development of obesity in hypertension.

Author Information

aDivision of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan, USA, bDipartimento di Medicina Clinica e Sperimentale, University of Padova, Padova, Italy and cCardiology Unit, University of Rochester, Rochester, New York, USA.

Sponsorship: The study was performed in the General Clinical Research Centre at the University of Michigan Medical Center (Grant #M01-RR0042).

Correspondence and request for reprints to Stevo Julius, Division of Cardiovascular Medicine, University of Michigan Medical Center, 3918 Taubman Center, Ann Arbor, MI 48109, USA. Tel: +1 734 9364 790; fax: +1 734 936 8898; e-mail:

Received 13 April 2004 Revised 1 June 2004 Accepted 11 June 2004

See editorial commentary on page 1869

© 2004 Lippincott Williams & Wilkins, Inc.